WordNet

a medicine promoting expectoration (同)expectorator
a substance that exerts some force or effect
a businessman who buys or sells for another in exchange for a commission (同)factor, broker
any agent or representative of a federal agency or bureau (同)federal agent
a representative who acts on behalf of other persons or organizations
an active and efficient cause; capable of producing a certain effect; "their research uncovered new disease agents"
how long something has existed; "it was replaced because of its age"
a time of life (usually defined in years) at which some particular qualification or power arises; "she was now of school age"; "tall for his eld" (同)eld
begin to seem older; get older; "The death of his wife caused him to age fast"
make older; "The death of his child aged him tremendously"

PrepTutorEJDIC

痰(たん)が出るのを促す / 去痰(きょたん)剤
『代理人』;周旋人 / 働き(作用)を起こすもの;作用物,薬剤 / (政府機関,特にFBI,CIAなどの)部員,機関員
〈U〉(一般に)『年齢』,寿命;〈C〉(個々の)『年齢』,年 / 〈U〉成年(おとなとしての資格・権利を得る年齢;通例18または21歳) / 〈U〉『老齢』;《集合的に》老人たち / 〈U〉(人生の)『一時期』;〈C〉世代(generation) / 〈U〉〈C〉《しばしばA-》(歴史上の)『時代』 / 〈C〉《話》長い間 / 年をとる,ふける;〈物が〉古くなる / 〈年〉'を'とらせる;〈物〉'を'古びさせる

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/07/26 01:01:46」(JST)

wiki en

[Wiki en表示]

Mucokinetics are a class of drugs which aid in the clearance of mucus from the airways, lungs, bronchi, and trachea. Such drugs can be further categorized by their mechanism of action:

mucolytic agents
expectorants
wetting agents / hypoviscosity agents
abhesives / surfactants

In general, clearance ability is hampered by bonding to surfaces (stickiness) and by the viscosity of mucous secretions in the lungs. In turn, the viscosity is dependent upon the concentration of mucoprotein in the secretions.

Expectorants and mucolytic agents are different types of medication, yet both are intended to promote drainage of mucus from the lungs.

An expectorant (from the Latin expectorare, to expel from the chest) works by signaling the body to increase the amount or hydration of secretions, resulting in more yet clearer secretions and as a byproduct lubricating the irritated respiratory tract. One expectorant, guaifenesin, is commonly available in many cough syrups. Often the term "expectorant" is incorrectly extended to any cough medicine, since it is a universal component.^[1]

A mucolytic agent is an agent which dissolves thick mucus and is usually used to help relieve respiratory difficulties. It does so by dissolving various chemical bonds within secretions, which in turn can lower the viscosity by altering the mucin-containing components.

Alternatively, attacking the affinity between secretions and the biological surfaces is another avenue, which is used by abhesives and surfactants.

Any of these effects could potentially improve airway clearance during coughing.

An expectorant increases bronchial secretions and mucolytics help loosen thick bronchial secretions. Expectorants reduce the thickness or viscosity of bronchial secretions thus increasing mucus flow that can be removed more easily through coughing. Mucolytics break down the chemical structure of mucus molecules. The mucus becomes thinner and can be removed more easily through coughing.

—Adams, Holland, & Bostwick, 2008, p. 591

Mucokinetic drugs

Mucolytics

Many mucolytic drugs are available, including acetylcysteine, ambroxol, carbocisteine, erdosteine, mecysteine, and dornase alfa (some brand names are listed in the related articles).

References

^ "Definition of Expectorant". MedicineNet. MedicineNet.com. Retrieved 14 December 2010.

Adams, Holland, & Bostwick (2008). Pharmacology for Nurses: A Pathophysiologic approach. Author. Upper Saddle River, New Jersey.
http://www.rcjournal.com/contents/07.02/07.02.0818.cfm
http://www.rcjournal.com/contents/07.07/07.07.0859.pdf

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. COPD治療における粘膜作用剤の役割 role of mucoactive agents in the treatment of copd
2. 成人における急性副鼻腔炎および鼻副鼻腔炎：治療 acute sinusitis and rhinosinusitis in adults treatment
3. 慢性閉塞性肺疾患の急性増悪のマネージメント management of acute exacerbations of chronic obstructive pulmonary disease
4. 成人における気管支拡張症の治療 treatment of bronchiectasis in adults
5. シェーグレン症候群におけるドライアイの治療 treatment of dry eyes in sjogrens syndrome

English Journal

After myringotomy, can topical Mesna application be an alternative method to ventilation tube application?

Karli R1, Ilkaya F, Karli A, Gunbey E, Kucuk H, Guzel H, Ayhan E.
European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery.Eur Arch Otorhinolaryngol.2015 May;272(5):1099-102. doi: 10.1007/s00405-014-2906-9. Epub 2014 Feb 8.
Sodium-2-mercaptoethanesulfonate (Mesna) is a mucolytic substance that is also used for chemically assisted tissue dissection in otological surgery. We investigated the effects of Mesna as a chemical agent on the closing time of perforation of the eardrum in an experimental animal model. We performe
PMID 24510178

The role of NF-κB signaling pathway in polyhexamethylene guanidine phosphate induced inflammatory response in mouse macrophage RAW264.7 cells.

Kim HR1, Shin da Y1, Chung KH2.
Toxicology letters.Toxicol Lett.2015 Mar 4;233(2):148-55. doi: 10.1016/j.toxlet.2015.01.005. Epub 2015 Jan 8.
Polyhexamethylene guanidine (PHMG) phosphate is a competitive disinfectant with strong antibacterial activity. However, epidemiologists revealed that inhaled PHMG-phosphate may increase the risk of pulmonary fibrosis associated with inflammation, resulting in the deaths of many people, including inf
PMID 25578230

Impaired autophagy induces chronic atrophic pancreatitis in mice via sex- and nutrition-dependent processes.

Diakopoulos KN1, Lesina M1, Wörmann S1, Song L1, Aichler M2, Schild L3, Artati A4, Römisch-Margl W4, Wartmann T5, Fischer R5, Kabiri Y6, Zischka H6, Halangk W5, Demir IE7, Pilsak C8, Walch A2, Mantzoros CS9, Steiner JM1, Erkan M10, Schmid RM1, Witt H8, Adamski J4, Algül H11.
Gastroenterology.Gastroenterology.2015 Mar;148(3):626-638.e17. doi: 10.1053/j.gastro.2014.12.003. Epub 2014 Dec 11.
BACKGROUND & AIMS: Little is known about the mechanisms of the progressive tissue destruction, inflammation, and fibrosis that occur during development of chronic pancreatitis. Autophagy is involved in multiple degenerative and inflammatory diseases, including pancreatitis, and requires the prot
PMID 25497209